Audentes Therapeutics

Audentes Therapeutics

Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases..

  • Edit

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2018201920202021202220232024
Revenues0000000000000000000000000000
EBITDA0000000000000000000000000000
Profit0000000000000000000000000000
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article

More about Audentes Therapeutics
Made with AI
Edit

Audentes Therapeutics focuses on developing gene therapy clinical programs aimed at treating rare diseases. The company serves patients and families affected by conditions such as X-Linked Myotubular Myopathy (XLMTM), Pompe Disease, Duchenne Muscular Dystrophy, and Myotonic Dystrophy Type 1. Operating within the biotechnology and pharmaceutical market, Audentes employs a patient-centric business model, integrating patient experiences and feedback into their development processes. Revenue is generated through the development and potential commercialization of gene therapies, as well as partnerships and collaborations with other biotech firms and research institutions. The company provides educational materials and resources to support the rare disease community, ensuring that patients and their families are well-informed and engaged throughout the clinical trial process.

Keywords: gene therapy, rare diseases, clinical development, patient-centric, biotechnology, pharmaceutical, X-Linked Myotubular Myopathy, Pompe Disease, Duchenne Muscular Dystrophy, Myotonic Dystrophy.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo